Cart contains    items

Browse by molecule: [A]  [B]  [C]  [D]  [E]  [F]  [G]  [H]  [I]  [J]  [K]  [L]  [M]  [N]  [O]  [P]  [Q]  [R]  [S]  [T]  [U]  [V]  [W]  [X]  [Y]  [Z]  

Epstein-Barr Virus Capsid Antigen BFRF3 Recombinant


accession:  P14348
   Size A       $
   Size B      0.5mg  $800
   Size C      1mg  $ 1100
Domain  : 
Gene  :  BFRF3
Catalog no. :  RKP14348
DNA sequence encoding immunodominant  fragment of Epstein-Barr Virus capsid BFRF3 protein expressed in Escherichia Coli.

Molecular weight:

Recombinant EBV p18 encodes the immunodominant sequences of theEpstein-Barr Virus capsid p18 protein. This molecule has a calculated mass of approximately 13kDa.

Recombinant EBV p18 contains an N terminal GST purification tag and migrates as an approximately 39 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE.

>95%, as determined by SDS-PAGE.

Recombinant human EBV p18 antigen is suitable for ELISA and Western blots, excellent antigen for detection of EBV with minimal specificity problems.


Immunoreactive with sera of EBV infected individuals.
Lyophilized from 25mM Tris-Hcl pH 7.2, 1mM EDTA and 50% glycerol.

A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.
Upon reconstitution, this protein can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity.

Avoid repeated freeze/thaw cycles.

This  product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.



EBV p18

There are 11 known antigenically distinct glycoproteins in herpes simplex virus type 1 (HSV-1) virions: gB, gC, gD, gE, gG, gI, gH, gJ, gK, gL, and gM. These glycoproteins are the primary inducers and targets of humoral immune responses in HSV infection and are also important inducers and targets of cell-mediated immune responses. In addition, some of the HSV glycoproteins have been shown to interact with specific components of the immune system. Most immunological and vaccine studies of the HSV-1 glycoproteins have focused on gD and/or gB. This is at least partially due to the fact that these are the most abundant HSV glycoproteins and therefore were the first two glycoproteins to be expressed and to be shown to provide protection against HSV infection in animal models.


by class:
Growth factors
CD markers
Viral Antigens
by species:
Purified Polyclonal
Related Products:
product_icon_8.jpg Epstein-Barr Virus Capsid Antigen BFRF3 Recombinant
Item name Size Quantity Price(USD) Remove
Cart Total $